Home › Funds › OPPENHEIMER & CO INC › GILD

OPPENHEIMER & CO INC position in GILD

GILEAD SCIENCES INC · Health Care

OPPENHEIMER & CO INC reported holding 257,035 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$38.3M, representing 0.40% of its reported portfolio and ranking #44 among its reported holdings. OPPENHEIMER & CO INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)257.04K sh
Reported value held$38.31M
Portfolio Weight0.40%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How OPPENHEIMER & CO INC's GILD position evolved

OPPENHEIMER & CO INC first disclosed a stake in GILD in Q3 2023 at 332,429 shares (US$24.9M). The position peaked in Q1 2026 at 283,045 shares, worth US$39.4M. Across 13 filings, OPPENHEIMER & CO INC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 257,035 shares valued at US$38.3M — a reduction of -2,175 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 332.43K $24.91M New
Q4 2023 299.03K $24.22M Reduce
Q1 2024 295.73K $21.66M Reduce
Q2 2024 288.47K $19.79M Reduce
Q3 2024 284.51K $23.85M Reduce
Q4 2024 286.34K $26.45M Add
Q1 2025 290.23K $32.52M Add
Q2 2025 297.46K $32.98M Add
Q3 2025 293.32K $32.56M Reduce
Q4 2025 268.10K $32.91M Reduce
Q1 2026 283.05K $39.45M Add
Q2 2026 259.21K $32.75M Reduce
Q3 2026 257.04K $38.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has OPPENHEIMER & CO INC held GILD?

OPPENHEIMER & CO INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is OPPENHEIMER & CO INC's current position in GILD?

As of Q3 2026, OPPENHEIMER & CO INC holds 257.04K shares of GILD (GILEAD SCIENCES INC), valued at $38.31M, representing 0.40% of its reported portfolio and ranking #44.

Has OPPENHEIMER & CO INC been buying or selling GILD?

In the latest 13F filing (Q3 2026), OPPENHEIMER & CO INC reduced its position in GILD. The position peaked in Q1 2026 at 283.05K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.